Literature DB >> 9260761

Gonadoblastomas in 45,X/46,XY mosaicism: analysis of Y chromosome distribution by fluorescence in situ hybridization.

J C Iezzoni1, C Von Kap-Herr, W L Golden, M J Gaffey.   

Abstract

Gonadoblastomas are composed of nests of neoplastic germ cells and sex cord derivatives surrounded by ovarian-type stroma. These tumors are found almost exclusively in persons with gonadal dysgenesis associated with a Y chromosome or Y chromosome fragment, and accordingly, the Y chromosome has been implicated in gonadoblastoma oncogenesis. To evaluate this association, we used two-color fluorescence in situ hybridization with chromosome-specific probes to determine the distribution of the X and Y chromosomes in the tumor nests and surrounding stromal cells in paraffin tissue sections of three gonadoblastomas in two patients with gonadal dysgenesis and 45,X/46,XY mosaicism. Statistical analysis of the data from the fluorescence in situ hybridization demonstrated that in all three gonadoblastomas, the proportion of nuclei with a Y chromosome signal was significantly higher in the tumor cells than in the nontumoral cells of the surrounding stroma (P<.001). These results suggest that Y chromosome material participates in gonadoblastoma tumorigenesis.

Entities:  

Mesh:

Year:  1997        PMID: 9260761     DOI: 10.1093/ajcp/108.2.197

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

Review 1.  Gonadoblastoma, testicular and prostate cancers, and the TSPY gene.

Authors:  Y F Lau
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  Prevalence and Physical Distribution of SRY in the Gonads of a Woman with Turner Syndrome: Phenotypic Presentation, Tubal Formation, and Malignancy Risk.

Authors:  Tamar G Baer; Christopher E Freeman; Claudia Cujar; Mahesh Mansukhani; Bahadur Singh; Xiaowei Chen; Rosanna Abellar; Sharon E Oberfield; Brynn Levy
Journal:  Horm Res Paediatr       Date:  2017-06-15       Impact factor: 2.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.